NORTHWEST BIOTHERAPEUTICS INC (NWBO): debt financing — NWBO enters $5M convertible note with Yorkville for Sawston facility

NORTHWEST BIOTHERAPEUTICS INC

Promissory note of $5M with YA II PN, Ltd. (Yorkville) for 12 months, no payments due until maturity.
Note carries 5% original issue discount, no interest, and convertible at a small discount to market price.
Monthly conversion limited to ~1/5 of note amount unless conversion price above $0.29.
Proceeds to fund construction/equipment for first Grade C manufacturing suite at Sawston, UK, plus operations.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

NORTHWEST BIOTHERAPEUTICS INC incurred convertible notes of $5 million with YA II PN, Ltd. at no interest maturing 12 months.

Instrument: convertible notes
Principal: $5 million
Counterparty: YA II PN, Ltd.
Rate: no interest
Maturity: 12 months
Event: incurrence

Exact text from the filing

On November 14, 2025 the Company entered into a $5 million convertible Promissory Note financing (the “Note”) with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global, LP (“Yorkville”).

View on SEC.gov

Browse all debt financings →

NORTHWEST BIOTHERAPEUTICS INC filing history →

Source: SEC EDGAR

accession 0001104659-25-114627

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.